Tiansheng Pharmaceutical Group Co EBIT TCAC 3A

Que fait Tiansheng Pharmaceutical Group Co ? Tiansheng Pharmaceutical Group Co., Ltd. generates revenue through the manufacturing and distribution of pharmaceutical products primarily within the domestic market. Its main products include pediatric lung cough particles, erythromycin enteric-coated capsules, silver ginseng Tongluo capsules, Salvia granules, Shugan Yi spleen granules, compound Ganoderma lucidum granules, Xiangdan injection, Qi and Diabetes tablets, liver capsule, Ling Jing capsule, lungs of nuclear paste, and Shen Qi Yi lung pill. The company focuses on domestic sales, targeting consumers seeking traditional Chinese medicine solutions for respiratory and digestive health. The firm's product portfolio emphasizes traditional Chinese medicine formulations, with specific offerings like Shugan Yi spleen granules for digestive issues and Ling Jing capsule for respiratory conditions. These products are distributed through domestic channels, catering to a market segment that prefers herbal remedies over conventional pharmaceuticals. Tiansheng's revenue stream is derived from the sale of these branded pharmaceutical items to pharmacies and healthcare providers within China. Tiansheng Pharmaceutical Group Co est l'une des entreprises les plus populaires sur Eulerpool.